APA

Seiden M. V., Gordon A. N., Bodurka D. C., Matulonis U. A., Penson R. T., Reed E., Alberts D. S., Weems G., Cullen M. & McGuire W. P. (20060427). A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. : Gynecologic oncology.

Chicago

Seiden Michael V, Gordon Alan N, Bodurka Diane C, Matulonis Ursula A, Penson Richard T, Reed Eddie, Alberts Dave S, Weems Garry, Cullen Michael and McGuire William P. 20060427. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. : Gynecologic oncology.

Harvard

Seiden M. V., Gordon A. N., Bodurka D. C., Matulonis U. A., Penson R. T., Reed E., Alberts D. S., Weems G., Cullen M. and McGuire W. P. (20060427). A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. : Gynecologic oncology.

MLA

Seiden Michael V, Gordon Alan N, Bodurka Diane C, Matulonis Ursula A, Penson Richard T, Reed Eddie, Alberts Dave S, Weems Garry, Cullen Michael and McGuire William P. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. : Gynecologic oncology. 20060427.